Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.924 |
High Similarity |
NPD8312 |
Approved |
0.924 |
High Similarity |
NPD8313 |
Approved |
0.8771 |
High Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8409 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8382 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8377 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8362 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8352 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8307 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.8307 |
Intermediate Similarity |
NPD7698 |
Approved |
0.8307 |
Intermediate Similarity |
NPD7697 |
Approved |
0.829 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.829 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.8268 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8263 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.8263 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.8258 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8246 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8245 |
Intermediate Similarity |
NPD6782 |
Approved |
0.8245 |
Intermediate Similarity |
NPD6781 |
Approved |
0.8245 |
Intermediate Similarity |
NPD6780 |
Approved |
0.8245 |
Intermediate Similarity |
NPD6776 |
Approved |
0.8245 |
Intermediate Similarity |
NPD6778 |
Approved |
0.8245 |
Intermediate Similarity |
NPD6777 |
Approved |
0.8245 |
Intermediate Similarity |
NPD6779 |
Approved |
0.8229 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.8222 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8211 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.8208 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8202 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8167 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8138 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.8138 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.8111 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8073 |
Intermediate Similarity |
NPD8319 |
Approved |
0.8073 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.8051 |
Intermediate Similarity |
NPD7874 |
Approved |
0.8051 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD3226 |
Approved |
0.801 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7989 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7979 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7979 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7969 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7944 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7931 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7926 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7926 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7926 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7921 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7886 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7861 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7849 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7845 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7833 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7814 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7797 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7745 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7701 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7701 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7627 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7571 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7554 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7514 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7513 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7476 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7476 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7474 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7472 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7414 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD3749 |
Approved |
0.74 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7384 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7366 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7326 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7302 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7288 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7283 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7253 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7241 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7209 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7209 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7209 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7209 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7198 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7189 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7182 |
Intermediate Similarity |
NPD37 |
Approved |
0.7175 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7158 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7158 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7158 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7151 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7119 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7115 |
Intermediate Similarity |
NPD7930 |
Approved |
0.711 |
Intermediate Similarity |
NPD2796 |
Approved |
0.711 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7101 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7085 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7045 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7039 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7035 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7022 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7011 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7005 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6994 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6976 |
Remote Similarity |
NPD7999 |
Approved |
0.6971 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD2798 |
Approved |
0.6961 |
Remote Similarity |
NPD7680 |
Approved |
0.6949 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6931 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.693 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD1240 |
Approved |
0.6911 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6897 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6891 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6882 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD1933 |
Approved |
0.6878 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6878 |
Remote Similarity |
NPD5710 |
Approved |
0.6878 |
Remote Similarity |
NPD5711 |
Approved |
0.6867 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD1201 |
Approved |
0.6865 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6865 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6857 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6847 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6827 |
Remote Similarity |
NPD7585 |
Approved |
0.6813 |
Remote Similarity |
NPD920 |
Approved |
0.6798 |
Remote Similarity |
NPD2800 |
Approved |
0.6788 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6782 |
Remote Similarity |
NPD447 |
Suspended |
0.678 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6779 |
Remote Similarity |
NPD7583 |
Approved |
0.6776 |
Remote Similarity |
NPD1653 |
Approved |
0.6766 |
Remote Similarity |
NPD1091 |
Approved |
0.6761 |
Remote Similarity |
NPD3748 |
Approved |
0.676 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6744 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6737 |
Remote Similarity |
NPD1247 |
Approved |
0.6729 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6724 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6723 |
Remote Similarity |
NPD2438 |
Suspended |
0.6722 |
Remote Similarity |
NPD6190 |
Approved |
0.672 |
Remote Similarity |
NPD919 |
Approved |
0.6706 |
Remote Similarity |
NPD1203 |
Approved |
0.6705 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6705 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6705 |
Remote Similarity |
NPD7985 |
Registered |
0.6705 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6705 |
Remote Similarity |
NPD3764 |
Approved |
0.6703 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6686
|
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |